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Polydiacetyleneprotein components in mammalian milk and have critical functions in calcium
transport and prevention of protein aggregation. Fibrillation and aggregation of κ-casein, a phenomenon
which has only recently been detected, might be associated with malfunctions of milk secretion and
amyloidosis phenomena in the mammary glands. This study employs a newly-designed chromatic
biomimetic vesicle assay to investigate the occurrence and the parameters affecting membrane interactions
of casein aggregates and the contribution of individual casein members to membrane binding. We show that
physiological casein colloids exhibit membrane activity, as well as early globular aggregates of κ-casein, a
prominent casein isoform. Furthermore, inhibition of κ-casein ﬁbrillation through complexation with αS-
casein and β-casein, respectively, was found to go hand in hand with induction of enhanced membrane
binding; these data are important in the context of casein biology since in secreted milk κ-casein is found
only in assemblies containing also αS-casein and β-casein. The chromatic experiments, complemented by
transmission electron microscopy analysis and ﬂuorescence quenching assays, also revealed signiﬁcantly
higher afﬁnity early spherical aggregates of k-casein to anionic phosphatidylglycerol-lipids, as compared to
zwitterionic phospholipids. Overall, this study suggests that lipid interactions play important roles in
maintaining the essential physiological functions of caseins in mammalian milk.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Caseins are the main protein elements of mammalian milk,
forming colloidal aggregates that give milk its opaque consistency
[1]. Caseins play an important role in cell uptake of physiologically-
important ions such as calcium and phosphate through formation of
soluble assemblies [2,3], and are also hypothesized to prevent protein
aggregation [4,5]. Several isoforms have been identiﬁed in the
heterogeneous casein protein family, includingαS1-casein,αS2-casein,
β-casein, and κ-casein. κ-Casein, in particular, has been proposed as a
stabilizing factor for casein micelles, while the other caseins are
primarily involved in calcium loading [6,7]. In natural milk, the caseins
compose soluble mixed colloids in which αS1-, αS2- and β-caseins are
embedded within the micelle interior, while the majority of the κ-
casein is surface displayed, forming a so-called “hairy layer” [1,8].
Recent studies reported the occurrence of distinct ﬁbrillation
phenomena involving caseins [9,10]. Amyloidogenic aggregates,
denoted corpora amylacea, comprising mineral ions and caseins havestoylphosphatidic acid; DMPC,
phosphatidylglycerol; DMPS,
l sulfate; ThT, Thioﬂavin T;
ihexadecanoyl-snglycero-3-
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l rights reserved.been identiﬁed in mammary gland deposits [11–13]. Several studies
reported in vitro experiments in which κ-casein formed elongated
ﬁbrils within several hours in physiological conditions [9,14]. The
aggregation process of κ-casein has been shown to be affected by
environmental factors such as temperature and metal ions [9,10].
Importantly, pronounced inhibition of κ-casein ﬁbrillation by αS-
casein and β-casein has also been detected [14]; this observation is
physiologically signiﬁcant since in milk κ-casein is found solely in
complexes comprising also αS-casein and β-casein.
The detection of casein ﬁbrillation might have distinct biological
implications in light of the pathologies and diseases associated with
protein misfolding and aggregation phenomena [15–17]. In particular,
membrane interactions of amyloidogenic proteins have been widely
observed and often have been implicated in cytotoxic effects and the
onset of pathological conditions [18–21]. The goal of this study is to
similarly assess whether casein aggregates exhibit lipid interactions,
and furthermore to decipher the contributions of individual casein
species and their mutual interactions towards membrane binding. In
particular, this study aims to shed light on the signiﬁcance of
membrane interactions in casein aggregation and disaggregation
processes, and to clarify whether lipid interactions have adverse
effects upon casein functionality or rather contribute to the physio-
logical roles of these proteins in milk.
The biomimetic chromatic lipid/polydiacetylene (PDA) vesicle
assay has been the primary bio-analytical platform employed in this
study [22,23]. The biomimetic membrane vesicular particles comprise
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polymer exhibiting unique color and ﬂuorescence properties [24,25].
Speciﬁcally, it has been shown that in mixed lipid/PDA particles the
PDA polymer undergoes dramatic blue–red and ﬂuorescence trans-
formations induced by membrane events occurring within the lipid
bilayer domains [26–28]. The chromatic changes of PDA correspond to
structural transitions of the polymer backbone, induced by molecular
interactions (and/or binding) with the lipid bilayers in themixed lipid/
PDA systems. In essence, many reports have demonstrated that PDA
can serve as a colorimetric and ﬂuorescence reporter of membrane
interactions in themixed vesicles [29,30]. In the context of this work, a
previous study has employed the lipid/PDA vesicle assay for detection
of membrane binding of pre-ﬁbrillar assemblies of the islet amyloid
polypeptide [31].
2. Materials and methods
2.1. Materials
Lipids including dimyristoylphosphatidylcholine (DMPC), dimyr-
istoylphosphatidylglycerol (DMPG), dimyristoylphosphatidylserine
(DMPS) and dimyristoylphosphatidic acid (DMPA) were purchased
from Avanti (Alabaster, AL). Thioﬂavin T (ThT), β-mercaptoethanol,
sodium dithionite (Na2O4S2), αS-, β-, and κ-casein from bovine milk
were purchased from Sigma-Aldrich Co. (St Louis, MO, USA). Casein
colloids from bovine milk were purchased from Calbiochem (EMD
Chemicals Inc., La Jolla, CA, USA). The proteins were used without
further puriﬁcation. The diacetylenic monomer, 10,12-tricosadiynoic
acid, was purchased from Alfa Aesar (Karlsruhe, Germany) and
puriﬁed by dissolving the powder in chloroform, ﬁltering the resulting
solution through a 0.45μm Nylon ﬁlter (Whatman Inc.), and evapora-
tion of the solvent. The ﬂuorescent probe, N-(7-nitrobenz-2-oxa-1,3-
diazol-4-yl)1,2-dihexadecanoyl-snglycero-3-phosphoethanolamine,
triethylammonium salt (NBD-PE) was purchased from Molecular
Probes (Eugene, OR, USA). Buffer solutions were passed through a
0.2μm Nylon ﬁlter (Whatman Inc.) to remove impurities.
2.2. Preparation of vesicles
All lipid constituentswere dissolved in chloroform/ethanol (1:1, v/v).
The components of each vesicle composition were dried together in
vacuo. Following evaporation, distilled water and 50 mM phosphate
buffer pH 7.0 was added for preparation of mixed phospholipid/PDA
assemblies and conventional phospholipid vesicles, respectively. The
suspensions bearing a total lipid concentration of 1mM, were probe-
sonicated using a Misonix Incorporated sonicator (Farmingdale, NY,
USA). Sonication of conventional phospholipid vesicles, containing only
DMPC or DMPG, was performed at room temperature for 10 min,
applying anoutput power of approximately 30W. For chromatic vesicles
containing phospholipids and the monomeric unit 10,12-tricosadiynoic
acid, at amolar ratio of 2:3, sonicationwas performed at 70 °C for 3min,
applying an output power of approximately 40 W. The vesicle solution
was then cooled to room temperature, incubated overnight at 4 °C, and
polymerized by irradiation at 254 nm for 0.3–0.5 min, resulting in
intense blue solutions.
2.3. Casein aggregation
αS-, β- and κ-casein (from bovine milk) were separately
dissolved in 50 mM phosphate buffer (pH 7.0) to a ﬁnal concentra-
tion of 8 mg/mL. To generate aggregates, protein solutions were
incubated at 37 °C without shaking. To prepare reduced κ-casein, 5%
v/v (0.7M) of β-mercaptoethanol was added to the protein solution
prior to incubation. Aggregate formation is temperature-dependent
and can be quenched by freezing the solutions [32]. Exploiting this
fact, 1 mL aliquots were withdrawn from the casein solutions atselected times and kept at −20 °C. Frozen samples were thawed
immediately prior to the different experiments conducted. The same
procedure was applied to natural casein colloids from bovine milk,
where the ﬁnal concentration was 27 mg/mL.
For separating the supernatant and aggregates, 900 μL κ-casein
samples were transferred to a microtube and ultracentrifuged for 1 h
at 45,000 rpm and 4 °C in a Beckman 47–65 ultracentrifuge (Beckman
Instruments Inc.) using an SW-55 rotor. The supernatant fractions
(150 μL) were transferred to another tube, and pellet fractions were
gently re-suspended in the remaining 750 μL.
Aggregate inhibition experiments employed κ-casein at the
approximate concentration present in bovine milk (160 μM; 3 mg/
mL [33]). This κ-casein solutionwas mixed with either αS- or β-casein
in a molar ratio of 1:3.
2.4. Thioﬂavin T (ThT) assay
5 μL samples extracted from the thawed protein samples were
mixed with 495 μL of 4 μM ThT in 10 mM phosphate buffer (pH 7.4).
The ﬂuorescence emission was recorded at room temperature using
440 nm excitation and 488 nm emission on an Edinburgh Co. FL920
spectroﬂuorimeter (Edinburgh, Scotland, UK).
2.5. In situ ThT assay
Twotypes of experimentswere conductedusing thismethod; at both,
κ-casein at 3 mg/mL was incubated with 10 μM ThT in Greiner 96-
microwell plates with cover. Plates were sealed with paraﬁlm to prevent
evaporation and incubated at 37 °C. The ﬂuorescence intensity was
measuredat30min intervals for25husingamultiwellﬂuorescenceplate
reader (Fluoroscan Ascent; Thermo, Finland) with a 430/485 nm
excitation/emission long path ﬁlter set. In the aggregation inhibition
experiments, κ-casein was mixed with either αS- or β-casein in a molar
ratio of 1:3 (for each protein). A total volume of 200 μLwas placed in each
well. Alternatively, in experiments for determining the effects of phos-
pholipids upon casein aggregation, κ-caseinwas incubatedwith ThT for 2
h. Subsequently, 15 μL solutions of the pure phospholipid vesicles (DMPC
or DMPG) were respectively added to each well up to a total volume of
200 μL, and theﬂuorescence recordingwas resumed. The presence of ThT
in the protein solution, at the concentrations used, did not affect the
kinetics of κ-casein aggregation [14,34]. During the early phase of
incubation ﬂuorescence reading was affected by change in temperature
as solutions were heated, resulting in an initial decrease in ThT ﬂuore-
scence. This optical artifact was removed by extrapolating the initial
ascending gradient of the aggregation curve back to the zero time point.
2.6. PDA ﬂuorescence assay
Samples were prepared by adding 20 μL of the thawed protein
solutions to 30 μL of the phospholipid/PDAvesicles, followed by addition
of 30 μL of 50mMTris base buffer (pH 8.2) and dilution in distilledwater
to a total volumeof 200 μL. Sampleswere placed inGreiner 96-microwell
plates. Fluorescence intensity was measured at 15 min intervals for 2 h
using amultiwell ﬂuorescence plate reader (Fluoroscan Ascent; Thermo,
Finland) with a 485/555 nm excitation/emission long path ﬁlter set. The
ﬂuorescence percentage calculated as percentage intensities compared
to the fully transformed red vesicles.
2.7. Transmission electron microscopy (TEM)
Casein samples for TEM measurements were prepared by diluting
the protein solutions to a concentration of 1 mg/mL. TEM samples of
mixtures of casein and lipid/PDA assemblies were prepared by mixing
20 μL of protein solutions with 30 μL of the vesicle and 30 μL of 50 mM
Tris base (pH 8.2). The mixtures were incubated for 30 min at room
temperature and diluted by distilled water to a total volume of 200 μL.
Fig. 1. Membrane interactions of casein colloids. Fluorescence emission (560 nm)
recorded in DMPG/PDA vesicles (solid line) and DMPC/PDA vesicles (broken line)
following addition of physiological casein colloids (27 mg/mL). The ﬂuorescence
percentage is relative to the ﬂuorescence of the red vesicles (maximum ﬂuorescence,
induced through heating to 50 °C).
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prepared by mixing 100 μL of κ-casein (3 mg/mL) with 100 μL of the
vesicles. The mixtures were incubated for 1 h at 37 °C and diluted by
50 mM phosphate buffer (pH 7.0) to a total volume of 300 μL. 5 μL
volumes were then placed on 400 mesh copper Formvar/carbon grids
(Electron Microscopy Sciences, Hatﬁeld, PA, USA). After 2 min, excess
ﬂuid was removed with a ﬁlter paper, and the grids were negatively
stained with 2% uranyl acetate in water for 30 s.
2.8. Fluorescence quenching
NBD-PE was added to the pure DMPC or DMPG vesicles at a molar
ratio of 1:100 (probe:phospholipid) and dried together in vacuo prior
to sonication. Samples were prepared by mixing 20 μL of protein
solutions at a concentration of 3mg/mLwith 30 μL of the phospholipid
vesicles containing the ﬂuorescent probe and 50 mM Tris base buffer
(pH 8.2), followed by addition of distilled water to a total volume of 1
mL. The quenching reactionwas initiated by adding sodium dithionite
from a stock solution of 0.6 M, prepared in 50 mM Tris base buffer (pH
11) to a ﬁnal concentration of 1 mM. The decrease in ﬂuorescence
emission was recorded for 5 min at room temperature using 469 nm
excitation and 530 nm emission on an Edinburgh Co. FL920 spectro-
ﬂuorimeter (Edinburgh, Scotland, UK). The ﬂuorescence emission
decay curve was calculated as a percentage of the initial ﬂuorescence
measured before the addition of dithionite.
2.9. Statistical analysis
All experiments were repeated at least three times at different
occasions; at least three measurements were carried for each
experimental set. Average results are presented in the ﬁgures with
corresponding standard deviations; in cases where the standard
deviations were less than 5% of the reported values, standard
deviations were omitted for presentation clarity. Control measure-
ments were carried for all experiments (i.e., measurements without
the addition of protein). In the ThT and vesicle ﬂuorescence
experiments, the net ﬂuorescence emission values are presented, i.e.
after subtraction of control ﬂuorescence.
3. Results
3.1. Membrane interactions of casein colloids and early aggregates
Colloidal particles of caseins comprise assemblies of κ-casein, αS1-
casein, αS2-casein, and β-casein [35]. The experiments summarized in
Fig. 1 were designed to evaluate the degree of membrane binding of
physiological casein colloids. Speciﬁcally, Fig. 1 depicts the ﬂuores-
cence emission recorded in phospholipids/PDA vesicular particle
solutions, induced through interactions with extracted natural casein
aggregates. Essentially, higher ﬂuorescence emission indicates more
pronounced disruption of the lipid/PDA assembly induced through
binding by the casein aggregates. Indeed, Fig. 1 points to signiﬁcant
membrane interactions by casein. The induced ﬂuorescence does not
seem to change over several hours— indicating relative stability of the
membrane-active species. Importantly, the graphs in Fig. 1 demon-
strate much higher ﬂuorescence induced by the casein colloids in the
DMPG/PDA solution compared to DMPC/PDA, ascribed to a stronger
afﬁnity of caseins to the phosphatidylglycerol-lipids.
While the experimental data in Fig. 1 point to the occurrence of
membrane interactions of the mixed casein colloids, we further aimed
to elucidate the contributions of individual casein members to lipid
afﬁnity and binding. The experiments depicted in Fig. 2 are designed to
evaluate the relationships between casein aggregation phenomena and
membrane binding. Fig. 2A depicts the ThT ﬂuorescence curves
recorded for κ-casein, αS-casein, and β-casein, respectively. Fig. 2A
conﬁrms that only κ-casein forms ﬁbrillar or ﬁbril-like aggregates,leading to an increase inThT ﬂuorescencewithin 24 h [14]. The addition
of β-mercaptoethanol to κ-casein (5% v/v, 700 mM) gave rise to
signiﬁcantly more pronounced increase in ﬁbril formation due to
rupturingof the disulﬁdebondswithin the protein (Fig. 2A, curve i) [14].
To probe the extent of membrane binding by the casein species
present in the aqueous solution during the aggregation process we
examined the chromatic transformations induced by the proteins
following their addition to phospholipid/PDA vesicular particles [22]
(Fig. 2B). Speciﬁcally, at distinct times after dissolution of each of the
casein isoforms, aliquots were extracted and added to the DMPC/PDA
and DMPG/PDA solutions, respectively. After equilibration of the
protein/vesicle mixtures we recorded the color transformations (Fig.
2B) or ﬂuorescence emission (Fig. 2C) of the vesicle solutions.
Fig. 2B demonstrates the effects of κ-casein upon the chromatic
properties of the lipid/PDA vesicular particles. Fig. 2Bi, for example,
shows that κ-casein dissolved in buffer and immediately added to
DMPC/PDA gave rise to a blue–red transition, exempliﬁed both in the
scanned picture of the solution (which exhibits a purple color) and the
visible spectrum depicting the increased peak at around 500 nm. In
contrast, κ-casein dissolved in buffer, incubated for 24 h and only then
added to the vesicular particles did not exert the same effect— instead
leaving the solution blue (Fig. 2Bii).
The ﬂuorescence emission curves depicted in Fig. 2C echo the
colorimetric data in Fig. 2B. Speciﬁcally, similar to the visible data in
Fig. 2B, Fig. 2C shows that κ-casein aliquots extracted after longer
incubation times gave rise to lower ﬂuorescence emission compared
to the ﬂuorescence induced by κ-casein immediately after dissolution.
This observationwas evident both in DMPC/PDA as well as DMPG/PDA
solutions (Fig. 2C). Furthermore, the ﬂuorescence data demonstrate a
signiﬁcant difference between the chromatic transformations induced
by κ-casein in DMPC/PDA vesicular particles and DMPG/PDA particles,
respectively (Fig. 2C). Speciﬁcally, the ﬂuorescence induced by κ-
casein (reduced as well as non-reduced) in DMPG/PDA vesicular
particles was evidently higher than the ﬂuorescence induced by the
protein following interaction with DMPC/PDA (Fig. 2C). In contrast to
κ-casein, the addition of αS-casein and β-casein to the lipid/PDA
vesicular particles gave rise tomuch lower ﬂuorescence emission, and,
furthermore, the ﬂuorescence emission stayed almost constant
throughout the experimental measurements (Fig. 2C).
The data depicted in Fig. 2C illuminate important aspects
concerning membrane interactions of caseins. First, the color and
ﬂuorescence transformations induced by κ-casein immediately after
dissolution in aqueous environment indicate the presence of
membrane-active molecular species which bind to the lipid/PDA
vesicular particles and consequently give rise to the chromatic
transformations of the conjugated polymer. Furthermore, the
Fig. 2. Casein aggregation and membrane interactions. (A) Time-dependent ThT ﬂuorescence curves of caseins (8 mg/mL): i. κ-casein to which β-mercaptoethanol was added;
ii. κ-casein; iii. αS-casein; iv. β-casein. (B) Color images and visible spectra of DMPC/PDA vesicular particles following addition of κ-casein (8 mg/mL): i. initially-dissolved κ-casein
added, ii. κ-casein added after 24-hour incubation; (C) Time-dependent ﬂuorescence emission induced in DMPC/PDA and DMPG/PDA vesicular particles, respectively, following
addition of caseins (8 mg/mL): i. κ-casein to which β-mercaptoethanol was added (5% v/v, 700 mM); ii. κ-casein; iii. β-casein; iv. αS-casein. The ﬂuorescence percentage is relative to
the ﬂuorescence of the red vesicles (maximum ﬂuorescence, induced through heating to 50 °C).
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species existing in solution following initial dissolution are progres-
sively eliminated as κ-casein ﬁbrils grow — eventually leading to the
signiﬁcantly lower ﬂuorescence induced by κ-casein in the lipid/PDA
vesicular particles after 24 h.
Fig. 2C also clearly demonstrates that membrane binding by the
early aggregates of κ-casein which appear immediately after protein
dissolution, depends upon the phospholipid headgroup. Speciﬁcally,
the chromatic response appeared more pronounced when the lipid/
PDA vesicular particles comprised DMPG, as compared to DMPC.
Indeed, examination of κ-casein interactions with vesicular particles
containing other phospholipids (Supporting Information, Fig. 1SI)highlighted the importance of the lipid headgroup in determining
membrane afﬁnity. The ﬂuorescence data in Fig. 2C further indicate
that αS-casein and β-casein in aqueous solution form species that are
less membrane-active compared to κ-casein, thus giving rise to much
lower ﬂuorescence within the phospholipid/PDA vesicular particles.
To further determine which species are actually the membrane-
active constituents in the κ-casein solution we ultracentrifuged the κ-
casein solution immediately after dissolution of the protein, and
evaluated membrane afﬁnities of the separate components — the
pellet containing early aggregates of κ-casein, and supernatant in
which putative soluble monomers and small oligomers are present
(Fig. 3). The ThT ﬂuorescence data in Fig. 3A indicates a high
Fig. 3. Membrane interactions of as-dissolved κ-casein assemblies (non-reduced) after
ultracentrifugation. (A) ThT ﬂuorescence assay of the κ-casein (non-reduced, 8 mg/mL)
aggregates (pellet) and lighter species (in the supernatant); the supernatant sampleswere
extracted fromthe top15% solution, similardatawere obtained for samples extracted from
the top 40% solution. (B) Fluorescence emission induced in DMPC/PDA vesicular particles
(white) and DMPG/PDA vesicular particles (grey) following addition of the soluble
κ-casein (8mg/mL)monomers and small oligomers (supernatant) and aggregates (pellet).
Fig. 5. Fluorescence quenching. Time-decay ﬂuorescence curves recorded following
addition of sodium dithionite to NBD-PE-containing DMPG (A) and DMPC (B) vesicles.
Solid curves: control vesicles [no κ-casein pre-added (non-reduced)]; broken curves: κ-
casein (3 mg/mL, non-reduced) added to the vesicles prior to dithionite.
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conﬁrms that the ultracentrifugation treatment precipitated the
κ-casein larger oligomers and early aggregates from the aqueous
solution (previous studies indicated that ThT binds both to the mature
ﬁbrillar aggregates and also smaller oligomeric species [9]). Impor-
tantly, Fig. 3B demonstrates a signiﬁcant difference between mem-
brane interactions of the re-suspended κ-casein aggregates and the
smaller molecular species in the supernatant; ﬂuorescence results
demonstrate that the early aggregates were the main membrane-Fig. 4. TEM of κ-casein added to DMPG/PDA vesicular particles. (A) Control DMPG/PDA ves
immediately after dissolution; (C) Addition of κ-casein (non-reduced, 8 mg/mL) that was inactive constituents in the as-dissolved κ-casein solution. A polyacry-
lamide SDS gel experiment (Supporting Information, Fig. 2SI) further
conﬁrmed that κ-casein monomers and small oligomers were present
in the supernatant suspension, while larger aggregates were abundant
in the dissolved κ-casein suspension overall.
Transmission electron microscopy (TEM) images were recorded to
visualize the structural features of the κ-casein aggregates and their
interactions with the phospholipid/PDA vesicular particles (Fig. 4).
Previous studies have identiﬁed small spherical κ-casein aggregatesicular particles (no κ-casein added); (B) Addition of κ-casein (non-reduced, 8 mg/mL)
cubated for 24 h. The bar corresponds to 200 nm.
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dissolution, forming elongated ﬁbrils after several hours [9,14,36]. The
representative TEM images in Fig. 4 depict similar aggregation
phenomena, and further illustrate κ-casein effects upon the chromatic
DMPG/PDA vesicular particles.
The TEM image of the as-prepared DMPG/PDA vesicular particles
depicts the typical rectangular aggregate conﬁguration, due to the
oriented structural organization of the PDA subunits within the
particles (Fig. 4A) [31,37]. Fig. 4B demonstrates the pronounced effect
of the κ-casein early aggregates, inducing “fraying” of the particle
surface, most likely due to binding of the κ-casein assemblies (shown
around the vesicle) to the embedded phospholipids. Aggregates of κ-
casein and phospholipids might be also apparent in the TEM image
(Fig. 4B, bottom left). In contrast, κ-casein incubated in water for 24 h
and then added to the DMPG/PDA vesicular particles appeared not to
affect the vesicle structure or morphology (Fig. 4C). The TEM image in
Fig. 4C shows the elongated κ-casein ﬁbrils around the vesicle;
however, different from the highly membrane-active pre-ﬁbril and
globular early aggregates (Fig. 4B), the mature ﬁbrils were neither
bound to, nor perturbing the vesicle surface (Fig. 4C).
Fluorescence quenching experiments employing the ﬂuorophore
NBD embedded in DMPC vesicles and DMPG vesicles, respectively,
were carried out to further evaluate the pronounced afﬁnity of κ-casein
to the anionic PG phospholipids (Fig. 5). In the experiments depicted in
Fig. 5, the ﬂuorescence quencher sodiumdithionitewas added toNBD-
PE/phospholipid vesicles, with and without prior addition of κ-casein.
In such experiments dithionite progressively induces quenching of the
vesicle-embedded NBD ﬂuorescence over time [38]. Fig. 5A, however,
reveals that pre-addition of freshly dissolved κ-casein to DMPG
vesicles resulted in signiﬁcantly faster quenching rate compared toFig. 6. Effects of phospholipids upon κ-casein aggregation. (A) Time-dependent ThT ﬂuore
vesicles (solid curve); following addition of DMPC vesicles (2 h after start of incubation, short
TEM images of κ-casein (non-reduced, ﬁnal concentration 1mg/mL): i. sample extracted after
DMPG vesicles in which elongated aggregates are formed; iii. sample extracted after 24-hothe control vesicles (no κ-casein added). Such an effect was not
observed when DMPC vesicles were inspected; in this system κ-casein
minimally altered the dithionite-induced ﬂuorescence quenching (Fig.
5B). The pronounced quenching induced by pre-addition of κ-casein to
NBD-PE/DMPGvesicles ismost likelya consequence of the high afﬁnity
and signiﬁcant interactions between the anionic phosphatidylglycerol
lipids and κ-casein species, resulting in exposure of the lipid-
incorporated NBD dye to the dithionite quencher. This interpretation
is consistent with the phospholipid/PDA assay results (Figs. 2–4).
3.2. Effect of lipid interactions upon κ-casein aggregation
While the experiments depicted in Figs. 2–5 indicate that pre-
ﬁbrillar and early spherical aggregate assemblies of κ-casein exhibit
pronounced interactions with phospholipid bilayers, another aspect of
such interactions is the reciprocal effect of the phospholipids upon the
aggregation process itself. Fig. 6 demonstrates that anionic phospho-
lipids gave rise to a dramatic enhancement of κ-casein ﬁbrillation
process. Speciﬁcally, in the experiments depicted in Fig. 6Aunilamellar
DMPG vesicles and DMPC vesicles, respectively, were added to κ-
casein solutions (further containing the ThT dye) approximately 2 h
after dissolution of the protein in buffer. The ThT ﬂuorescence curves
showan instant, substantial increase in aggregation following addition
of unilamellar DMPG vesicles to the protein solution (long-dash curve
in Fig. 6A). Such an increase did not occur when zwitterionic DMPC
vesicles were added to κ-casein (Fig. 6A, short dash).
TEM analysis in Fig. 6B further illuminates the structural
consequences resulting from addition of DMPG to the κ-casein
solutions. κ-Casein forms annular aggregates after dissolution in
buffer (Fig. 6Bi) [36]. Addition of unilamellar DMPC vesicles seemedscence curves of κ-casein (non-reduced, 3 mg/mL): without addition of phospholipids
dash); following addition of DMPG vesicles (2 h after start of incubation, long dash); (B)
dissolution in buffer showing spherical aggregates; ii. sample extracted after addition of
ur incubation at 37 °C (no DMPG added), casein ﬁbrils observed. Scale bars: 200 nm.
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aggregates (data not shown — images very similar to Fig. 6Bi).
However, the addition of DMPG to κ-casein had a dramatic structural
effect, giving rise to agglomeration of the casein aggregates, which
rapidly formed large elongated structures (Fig. 6Bii). This aggregation
is consistent with the ThT ﬂuorescence results (Fig. 6A), and the
enhanced chromatic transformations induced by κ-casein early
aggregates in DMPG/PDA vesicular particles (Figs. 2–4).
The TEM analysis in Fig. 6B further underscores the different
structures of the DMPG-induced elongated ﬁbril-like aggregates (Fig.
6Bii) compared to the self-assembled ﬁbrils formed after long
incubation in aqueous solution (Fig. 6Biii). Speciﬁcally, the DMPG-
induced assemblies appear thicker, longer, and somewhat less
organized than the 24-hour buffer-incubated κ-casein ﬁbrils which
seem much narrower and uniform in diameter. This difference is
possibly ascribed to the rapid inducement of ﬁbrillation by the anionicFig. 7. Inhibition of κ-casein ﬁbrillation: (A) ThT ﬂuorescence curves: non-reduced κ-casei
κ-casein only (short dash). (B) Fluorescence induced by the peptide mixtures after mixing
κ-casein+αS-casein (solid curve); non-reduced κ-casein+β-casein (broken curve). The i
(C) TEM of casein mixtures after 24-hour incubation: i. non-reduced κ-casein+αS-casein
κ-casein concentration was 3 mg/mL and the molar ratio between κ-casein and αS-casephospholipids vs. the slow assembly process of caseins in lipid-free
aqueous solutions.
3.3. Inhibition of κ-casein aggregation
Addition of either αS-casein or β-casein to κ-casein has been
shown to signiﬁcantly inhibit the formation of κ-casein ﬁbrils [14].
Furthermore, understanding the interactions between κ-casein and
the two other casein isoforms is important since in milk κ-casein is
found only in complexes with αS-casein and β-casein [39,40]. We
carried out experiments to examine the consequences of inhibiting κ-
casein aggregation upon its membrane interactions (Fig. 7). The ThT
data in Fig. 7A conﬁrm that formation of κ-casein ﬁbrillar aggregates is
considerably diminished following mixing of the protein with either
αS-casein or β-casein [14]. However, examination of the ﬂuorescence
induced by the αS-casein/κ-casein or β-casein/κ-casein mixtures inn+αS-casein (solid curve); non-reduced κ-casein+β-casein (long dash); non-reduced
with phospholipid/PDA vesicular particles: i. DMPC/PDA; ii. DMPG/PDA; non-reduced
ndividual contributions of κ-casein, and of αS-casein or β-casein were subtracted.
; ii. non-reduced κ-casein+β-casein. Bar corresponds to 200 nm. In all experiments
in or β-casein was 1:3.
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in membrane interactions (Fig. 7B).
Indeed, the solid curves in Fig. 7B indicate that pre-addition of αS-
casein to κ-casein induced higher ﬂuorescence, in both DMPC/PDA and
DMPG/PDA solutions, in several samples extracted at different times
throughout the incubation period (up to 24-hour incubation).
Importantly, the ﬂuorescence values depicted in Fig. 7B are the net
ﬂuorescence emissions — obtained following subtraction of the
ﬂuorescence induced by un-inhibited κ-casein, and ﬂuorescence
induced by αS-casein or β-casein individually, in the different time-
points. Accordingly, Fig. 7B indicates that inhibition of κ-casein
ﬁbrillation by αS-casein went hand in hand with higher membrane
activity, giving rise to higher ﬂuorescence emission in the phospho-
lipid/PDAvesicular particles. The consequences of β-casein addition to
κ-casein were notably different than αS-casein (broken curves in Fig.
7B). In particular, the β-casein/κ-casein mixtures did not give rise to
enhancement of ﬂuorescence following interactions with DMPC/PDA,
while a net ﬂuorescence that was constant in timewas induced by the
complex in the DMPG/PDA solution. These data indicate that the
pronounced inhibition of κ-casein ﬁbrillation by β-casein was not
accompanied by an enhanced time-dependent formation of mem-
brane-bound assemblies, as was the case with αS-casein.
The TEM images in Fig. 7C suggest that differences in the structural
features of the early annular aggregate assemblies within the casein
mixtures might account for the distinct membrane interaction proﬁles
recorded in Fig. 7B. The prominent species in the αS-casein/κ-casein
mixtures were small aggregates at diameters of approximately 10nm
(Fig. 7Ci), similar in size and appearance to the membrane-active
early spherical aggregates of κ-casein (TEM image in Fig. 6Bi).
However, examination of the effect of β-casein addition to κ-casein
reveals an abundance of bigger aggregates (Fig. 7Cii); the minimal
disruption of lipid bilayers by these species is most likely due to their
larger size.
4. Discussion
As the main protein components of mammalian milk, caseins have
key physiological functions. Caseins are naturally present inmammalian
milk as stable soluble colloids, however κ-casein, one of the main
constituents of casein aggregates, was found to undergo distinctive
ﬁbrillation process when individually dissolved in water [9]. These
seemingly contrasting properties suggest that casein self-assembly and
aggregation phenomena reﬂect distinct biological functions. This study
aims to both determine whether casein aggregates exhibit membrane
interactions, as well as evaluate the parameters and contributions of
different casein members towards membrane binding.
The relationship between membrane interactions and protein
misfolding and aggregation has attracted signiﬁcant interest in recent
years. Several studies have proposed that the severe toxicity of amyloid
diseases is closely related to interactions of amyloid aggregates with
the cell membrane, and interactions between amyloidogenic species
with model membrane systems have been reported [41–44]. Recent
publications have further suggested that pre-ﬁbrillar protein aggre-
gates and oligomer assemblies precede the formation of protein
amyloids, and that such proto-ﬁbrils are, in fact, the toxic factors in
amyloid diseases, rather than the mature ﬁbrils [45–48].
The experimental data presented here indicate that membrane
interactions are generic features in casein biology, both in the
natural colloidal state and also in in vitro aggregation processes.
Employing the chromatic lipid/PDA biomimetic assay we detected
signiﬁcant membrane activities for naturally-occurring casein col-
loids in milk (Fig. 1), transient κ-casein oligomers and early globular
aggregates (Figs. 2–5), and complexes of κ-casein with either αS-
casein or β-casein (Fig. 6). In agreement with our results, interac-
tions of caseins with PC- and PG-containing lipid vesicles have been
reported [49]. Application of the chromatic assay, in conjunctionwith monitoring of ThT ﬂuorescence and TEM experiments, probed
the extent of lipid binding by different aggregated forms of casein. In
the case of κ-casein, in particular, our analyses indicate that
transient pre-ﬁbril oligomers and early spherical aggregates, rather
than soluble species (monomers and small oligomers) or the later-
stage ﬁbrils, are the main species implicated in membrane interac-
tions. The chromatic analysis clearly demonstrated that membrane
binding decreases over time — a consequence of the gradual
aggregation of the membrane-active κ-casein oligomers into larger,
membrane-inactive, ﬁbrils.
Fluorescence analyses, employing both ThT assays and the
chromatic vesicles, complemented by TEM experiments and NBD
quenching, highlighted the signiﬁcance of the phospholipid head-
group in affecting κ-casein interactions with membranes. The
experiments demonstrated that early aggregates of κ-casein exhib-
ited higher afﬁnity to DMPG/PDA vesicular particles, compared to
DMPC/PDA. Furthermore, ThT analysis revealed a remarkable rapid
ﬁbrillation process induced by addition of DMPG vesicles to κ-casein.
Both experiments provided clear evidence of the signiﬁcant afﬁnity
of κ-casein to the phosphatidylglycerol-lipids. TEM images addition-
ally provided vivid visual evidence for the rapid formation of
elongated aggregates as a consequence of κ-casein/DMPG interac-
tions (Fig. 6). Further experiments examining other phospholipids
(Supporting Information, Fig. 2) conﬁrmed the dependence of κ-
casein/membrane interactions upon the type of phospholipid
headgroup.
Our results point to intriguing structural and functional conse-
quences of κ-casein aggregate inhibition by αS-casein and β-casein.
Both αS-casein and β-casein gave rise to formation of membrane-
active assemblies following addition to κ-casein. However, while αS-
casein seemed to induce a proliferation of highly membrane-active
aggregates, inhibition by β-casein induced larger colloidal aggregates
that displayed similar bilayer interactions as the spherical particles of
κ-casein (Fig. 7). This result is important because it points to the
particular signiﬁcance of αS-casein in maintaining casein solubility
and physiological functions in milk. Indeed, the effects of αS-casein
and β-casein upon membrane interactions of the resultant casein
complexes are particularly important in the context of casein biology,
because in natural mammalian milk κ-casein is found only in
complexes with αS-casein and β-casein, rather than as individual
species [39,40].
The observation of enhanced membrane interactions following
complex formation between κ-casein and αS-casein or β-casein
(particularly the αS-casein/κ-casein aggregates) suggests that an
important function of the multi-protein casein colloids in milk is to
facilitate membrane binding, rather than preventing it. Based upon
this interpretation, the higher afﬁnity of the casein entities to
phosphatidylglycerol might reﬂect enhanced casein interactions
with speciﬁc lipid species in the plasma membrane. Previous studies
have similarly reported adsorption of milk proteins to PC- and PG-
containing vesicles [49].
Importantly, interactions of the casein aggregates with PG are not
electrostatic in nature since κ-casein is negatively-charged in the
physiological pH of milk [50]. An alternative mechanism might
involve afﬁnity between the phospholipids and hydrophobic facets
of the casein aggregates, formed by κ-casein which is localized on
the surface of physiological casein colloids. Taken together, the
experiments depicted in this study suggest that membrane interac-
tions are inherent and fundamental to the normal functionality of
milk caseins.
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